Phibro Animal Health (PAHC) Short-term Investments (2017 - 2026)

Phibro Animal Health's Short-term Investments history runs 10 years deep, the most recent figure standing at $22.5 million for Q1 2026.

• On a quarterly basis, Short-term Investments rose 125.22% year-over-year to $22.5 million in Q1 2026; TTM through Mar 2026 was $22.5 million, a 125.22% increase from a year earlier, with the FY2025 full-year figure at $9.0 million, down 79.55% from the prior year.
• Short-term Investments climbed to $22.5 million in Q1 2026 per PAHC's latest filing, from $19.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $59.5 million in Q4 2023 and bottomed at $9.0 million in Q2 2025.
• The 5-year median for Short-term Investments is $22.3 million (2022), against an average of $28.1 million.
• Across the five-year window, Short-term Investments plunged 82.14% in 2022 and jumped 495.23% in 2023, its largest moves.
• Year by year, Short-term Investments stood at $10.0 million in 2022, then soared by 495.23% to $59.5 million in 2023, then sank by 36.16% to $38.0 million in 2024, then tumbled by 49.94% to $19.0 million in 2025, then grew by 18.4% to $22.5 million in 2026.
• Per Business Quant, the three latest PAHC Short-term Investments figures stand at $22.5 million (Q1 2026), $19.0 million (Q4 2025), and $12.5 million (Q3 2025).